الجزارا فارسی
روایت خاورمیانه 
Amid the numerous challenges facing the UK health system, distrust in technology companies, particularly Palantir, is becoming a serious concern. Recent statistics show that tens of thousands of patients have decided to withdraw their data from research projects, which could negatively affect the quality and quantity of NHS research.
Patient Data is at Risk
James Freed, the Minister of Health Innovation, has recently expressed concern that distrust in Palantir, a technology company known for its collaborations with the US Department of Defense and health projects, could lead to a decreased willingness among patients to share their data. This distrust not only jeopardizes the integrity of research but could also impact decision-making processes within the health system as a whole.
This issue arises at a time when the NHS heavily relies on patient data to improve its services and advance clinical research. With an increasing number of patients avoiding sharing their data for various reasons, experts have concluded that this trend may lead to a decline in the quality of healthcare services.
Potential Impacts on Health Research
Freed also pointed out that it should be noted that distrust in Palantir could turn into a crisis in clinical data collection. Many patients feel that their data is not being adequately protected, and this could lead to a decrease in their participation in research projects. This situation is particularly concerning given that the NHS requires continuous improvement in the quality of its services.
Ultimately, distrust in Palantir and its impact on the NHS could become a significant challenge for the UK health system. If this trend continues, not only scientific research but also the quality of healthcare services will be at risk.
